Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

about

PCL and PCL-based materials in biomedical applications.

P2860

Q47426635-6225F85D-EC42-4443-B5A6-1B4E9AB04F4F

P2860

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

Item

http://www.wikidata.org/entity/Q38848536

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

@en

type

Item

label

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

@en

prefLabel

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

@en

P1476

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

@en

P2093

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Liming Zhang

http://www.w3.org/2001/XMLSchema#string

Lipeng Zhou

http://www.w3.org/2001/XMLSchema#string

Shanshan Zhu

http://www.w3.org/2001/XMLSchema#string

Yongbin Chi

http://www.w3.org/2001/XMLSchema#string

Yuechu Dai

http://www.w3.org/2001/XMLSchema#string

Zhaoyun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure

Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Mechanisms of endocytosis

Primary brain tumours in adults.

Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids.

Investigating the optimal size of anticancer nanomedicine.

NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseases.

Strategies to advance translational research into brain barriers.

Pharmacokinetics and biodistribution of nanoparticles.

Active targeting schemes for nanoparticle systems in cancer therapeutics.

P304

224-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2015.1070854

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26219518

http://www.w3.org/2001/XMLSchema#string

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

about

P2860

P2860

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698